Cargando…
Development and evaluation of chitosan based oral controlled matrix tablets of losartan potassium
AIM AND BACKGROUND: The novelty of the present study was to control the release profile of matrix tablets of losartan potassium prepared by using different concentrations of chitosan and trisodium citrate as cross-linking agent with combination of various release retardant polymers. MATERIALS AND ME...
Autores principales: | Rao, Tallapaneni Vishnuvardhan, Kumar, GB Kiran, Ahmed, Mohammed Gulzar, Joshi, Vedamurthy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555011/ https://www.ncbi.nlm.nih.gov/pubmed/23373007 http://dx.doi.org/10.4103/2230-973X.104399 |
Ejemplares similares
-
Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression
por: Luo, Qiuhua, et al.
Publicado: (2022) -
Design and Evaluation of Losartan Potassium Effervescent Floating Matrix Tablets: In Vivo X-ray Imaging and Pharmacokinetic Studies in Albino Rabbits
por: Rahamathulla, Mohamed, et al.
Publicado: (2021) -
Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
por: Bajpai, M., et al.
Publicado: (2012) -
Human Bioequivalence Evaluation of Two Losartan Potassium Tablets Under Fasting Conditions
por: Das, A. K., et al.
Publicado: (2015) -
Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
por: Elezaj, Valentinë, et al.
Publicado: (2022)